Company profile: BioFactura
1.1 - Company Overview
Company description
- Provider of biopharmaceutical research and manufacturing solutions, offering the StableFast Biomanufacturing Platform to rapidly generate stable NS0 cell lines with a chemically defined production medium, modular expression vectors, and a proprietary growth supplement; development of biosimilars for autoimmune and infectious diseases; antibody-based smallpox and Marburg therapeutics with USAMRIID; and upstream, downstream, and analytical assay services.
Products and services
- Bioprocess Development and Manufacturing: Delivers mammalian-cell-based upstream development, downstream recovery/purification, and rigorous in-process and release analytical assays to advance biopharmaceutical production from cell culture optimization through product purification
- Biosimilars: Architects biosimilar-class follow-on biologics and generic biopharmaceuticals for autoimmune and infectious diseases, progressing programs from development through commercialization to serve these indications
- StableFast Biomanufacturing Platform: Engineers rapid generation of stable NS0 cell lines via chemically-defined, serum- and cholesterol-free production medium, modular expression vectors, pre-adapted parental cells, and a proprietary growth supplement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioFactura
Fortrea
HQ: United States
Website
- Description: Provider of comprehensive Phase I-IV clinical trial management, clinical pharmacology, patient access solutions, and other enabling services for biopharma and medical device and diagnostic companies, including medical device and diagnostic development, global regulatory submissions, and protocol development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fortrea company profile →
Amatsigroup
HQ: France
Website
- Description: Provider of GLP- and GMP-compliant CRO/CMO services for human and veterinary pharmaceutical product development, leveraging the expertise of renowned CROs/CMOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amatsigroup company profile →
Kentucky Clinical Trials Laboratory
HQ: United States
Website
- Description: Provider of pharmaceutical and diagnostic clinical trials, specimen collection, and medical studies to support research, development, and regulatory transition of novel products in medicine for business organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kentucky Clinical Trials Laboratory company profile →
Nanopharm
HQ: United Kingdom
Website
- Description: Provider of science-driven orally inhaled and nasal drug product design and development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanopharm company profile →
ShangPharma Innovation
HQ: United States
Website
- Description: Provider of global innovation incubation and investment focused on biomedical R&D technologies and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ShangPharma Innovation company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioFactura
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioFactura
2.2 - Growth funds investing in similar companies to BioFactura
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioFactura
4.2 - Public trading comparable groups for BioFactura
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →